Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Research Journal

The science, examined.

Plain-spoken notes on the compounds we supply — what the literature shows, how to read a COA, and the protocols that protect your data. Cited, never hyped.

All Bioregulators Comparisons Guides Gut Hormonal Immune In the news Metabolic & longevity Methods & QC Nootropics Regulation Sexual health Skin & matrix Sleep Tissue repair
Mimrylo (Rusfertide): The FDA Just Approved a Peptide That Mimics a Hormone Most People Have Never Heard Of In the news
Latest

Mimrylo (Rusfertide): The FDA Just Approved a Peptide That Mimics a Hormone Most People Have Never Heard Of

On 28 August 2026 FDA approved Mimrylo (rusfertide) for polycythemia vera — the first hepcidin-mimetic peptide medicine. The mechanism is iron restriction, and it is a case study in engineering…

Aug 2026 · 5 min read
Avexitide: The Peptide That Blocks the Receptor Ozempic Activates In the news

Avexitide: The Peptide That Blocks the Receptor Ozempic Activates

Avexitide is a GLP-1 receptor antagonist — the same target as semaglutide, the opposite direction. In August 2026 it cut severe hypoglycaemic events by…

Aug 2026 · 5 min read
Peptides Go Mainstream: What Hims & Hers’ 2026 Move Tells Us About the Category In the news

Peptides Go Mainstream: What Hims & Hers’ 2026 Move Tells Us About the Category

A listed telehealth company with 2.9 million subscribers is preparing to sell peptides, and is already running stability testing on BPC-157. What that says…

Aug 2026 · 7 min read
The One Peptide the FDA Panel Rejected — and Why That Vote Is the Most Informative of All In the news

The One Peptide the FDA Panel Rejected — and Why That Vote Is the Most Informative of All

At the FDA's July 2026 compounding panel, six peptides passed and one failed: emideltide (DSIP). Why that single rejection is the most revealing vote…

Aug 2026 · 8 min read
Samsung Biologics’ $1.8 Billion Bid for PolyPeptide: Why the Money Is Moving Into Peptide Manufacturing Capacity In the news

Samsung Biologics’ $1.8 Billion Bid for PolyPeptide: Why the Money Is Moving Into Peptide Manufacturing Capacity

Samsung Biologics has bid CHF 1.46bn for Swiss peptide CDMO PolyPeptide. A sober look at what the deal says about manufacturing capacity, and what…

Aug 2026 · 6 min read
Retatrutide Cleared Two More Phase 3 Trials — and Missed the Thing That Mattered Most In the news

Retatrutide Cleared Two More Phase 3 Trials — and Missed the Thing That Mattered Most

Lilly's retatrutide passed TRIUMPH-2 and TRIUMPH-3 in July 2026 — but missed on cardiovascular events, and the FDA filing slipped to Q1 2027. An…

Aug 2026 · 7 min read
The FDA Did Not Approve Six Peptides: What the July 2026 Compounding Vote Actually Was In the news

The FDA Did Not Approve Six Peptides: What the July 2026 Compounding Vote Actually Was

An FDA panel recommended six of seven peptides for the 503A compounding list on 23-24 July 2026. That is not approval. What the vote…

Jul 2026 · 10 min read
Which Peptides Has Andrew Huberman Said He Uses? In the news

Which Peptides Has Andrew Huberman Said He Uses?

Which peptides Andrew Huberman has said he personally uses — pinealon, BPC-157, sermorelin — and what the primary literature actually shows about each.

Jul 2026 · 8 min read
Every Peptide Bryan Johnson Has Tried — and Why He Dropped Most of Them In the news

Every Peptide Bryan Johnson Has Tried — and Why He Dropped Most of Them

Bryan Johnson has trialed CJC-1295, HGH, tirzepatide, cerebrolysin, epithalon, follistatin and BPC-157. A sourced look at what he measured, kept, and dropped.

Jul 2026 · 8 min read
Joe Rogan’s Peptide Use, Fact-Checked In the news

Joe Rogan’s Peptide Use, Fact-Checked

Joe Rogan says he uses BPC-157 and TB-500 to heal injuries. We fact-check the claims against the actual literature — what holds up, what…

Jul 2026 · 6 min read
Peter Attia on Peptides and Longevity Drugs, Fact-Checked In the news

Peter Attia on Peptides and Longevity Drugs, Fact-Checked

A source-checked look at where Peter Attia actually stands on NMN, rapamycin, metformin, GLP-1 drugs and BPC-157 — and where popular hype runs past…

Jul 2026 · 7 min read
Gary Brecka’s Peptide and Longevity Claims, Fact-Checked In the news

Gary Brecka’s Peptide and Longevity Claims, Fact-Checked

A source-checked look at Gary Brecka's claims on methylene blue, BPC-157, NAD+ and hydrogen — what the literature actually shows, and where certainty outruns…

Jul 2026 · 8 min read
Previous Page 1 of 2 Next

New research, in your inbox

Occasional, considered notes on the compounds and the literature. No noise.

Subscribe & earn 500 points